GMED (Globus Medical) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMED Globus Medical Inc GMED
95 GF Score
Price $74.08
GF Value $97.01
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Globus Medical  (NYSE:GMED) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Globus Medical Cyclically Adjusted PS Ratio Related Terms


Globus Medical Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Globus Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Cyclically Adjusted PS Ratio Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.16 9.26 5.89 7.90 7.20

Globus Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.21 4.86 7.18 6.76 5.96

GMED vs GKOS, BIO, PODD: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Globus Medical's Cyclically Adjusted PS Ratio falls into.


GMED
95GF Score
Globus Medical Inc GMED
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Globus Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Globus Medical's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.747/333.9520*333.9520
=5.747

Current CPI (Jun. 2026) = 333.9520.

Globus Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.406 241.428 1.945
201612 1.571 241.432 2.173
201703 1.604 243.801 2.197
201706 1.558 244.955 2.124
201709 1.551 246.819 2.099
201712 1.783 246.524 2.415
201803 1.736 249.554 2.323
201806 1.708 251.989 2.264
201809 1.662 252.439 2.199
201812 1.928 251.233 2.563
201903 1.805 254.202 2.371
201906 1.915 256.143 2.497
201909 1.922 256.759 2.500
201912 2.056 256.974 2.672
202003 1.866 258.115 2.414
202006 1.527 257.797 1.978
202009 2.151 260.280 2.760
202012 2.302 260.474 2.951
202103 2.220 264.877 2.799
202106 2.426 271.696 2.982
202109 2.200 274.310 2.678
202112 2.400 278.802 2.875
202203 2.215 287.504 2.573
202206 2.563 296.311 2.889
202209 2.506 296.808 2.820
202212 2.686 296.797 3.022
202303 2.707 301.836 2.995
202306 2.865 305.109 3.136
202309 3.329 307.789 3.612
202312 4.435 306.746 4.828
202403 4.482 312.332 4.792
202406 4.597 314.175 4.886
202409 4.532 315.301 4.800
202412 4.705 315.605 4.979
202503 4.279 319.799 4.468
202506 5.460 322.561 5.653
202509 5.680 324.800 5.840
202512 6.051 324.054 6.236
202603 5.499 330.213 5.561
202606 5.747 333.952 5.747

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Globus Medical (GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of $74.08 is trading 23.6% below its estimated GF Value™ of $97.01. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for GMED:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $97.01 vs. price of $74.08 (23.6% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Other Exchanges GMED:MexicoGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
95GF Score

Get the complete analysis for GMED

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$74.08
Price
$97.01
GF Value